IPO Key Dates
| Anchor Investor Subscription | |
| IPO opens on | 30 Sept. 2025 |
| IPO Closes on | 3 Octo 2025 |
| Allotment on | 6 Octo. 2025 |
| Credit of shares on | 7 Octo. 2025 |
| Tentative Listing on | 8 Octo.2025 |
| Registered office in.. |
| South Delhi |
| Lead Manager of the IPO |
| Narnolia Financial Services ltd |
| Registrar to the IPO |
| Skyline Finacial Services Pvt ltd. |
Business:
Incorporated in November 1991, Sheel Biotech Ltd. is engaged in biotechnology, floriculture, greenhouse projects and organic farming solutions. The company supplies a wide range of plants for field crops, fruits, vegetables and ornamentals through tissue culture and organic methods.
It also manufactures and maintains greenhouses, provides farmer services and training through FPOs, and undertakes landscaping projects for both government and private clients. The company’s operations are backed by ISO 9001:2015, 14001:2015 and 45001:2018 certifications, ensuring focus on quality, environmental responsibility and workplace safety.
IPO Details
| IPO opens on | 30 September 2025 |
| IPO closes on | 3 October 2025 |
| Issue Type | Book Built Issue IPO |
| Issue Size | 5400,000 Shares / Rs 34.02 Crore |
| * Fresh Issue | – |
| * Offer for Sale – | – |
| Market Maker Portion | 272,000 Shares |
| Net offer to Public | 5128000 Shares Rs. 32.31 Crores |
| Face Value per share | Rs. 10 |
| Price Band | Rs. 59-63 |
| Employee discount | Rs. 0 per share |
| Retail Lot Size | 2000 Shares |
| Listing will at | NSE SME |
How shares are being offered
| Investor Category | Shares Offered |
| Market Maker | 5.38% |
| QIB | 24,54,000 |
| NII (HNI) | 14.30% |
| Retail | 33.14% |
| Total Shares | 100 |
| Application | Lots | Shares | Amount |
| Retail (Min) | 2 | 4,000 | ₹2,52,000 |
| Retail (Max) | 2 | 4,000 | ₹2,52,000 |
| S-HNI (Min) | 3 | 6,000 | ₹3,78,000 |
| S-HNI (Max) | 7 | 14,000 | ₹8,82,000 |
| B-HNI (Min) | 8 | 16,000 | ₹10,08,000 |
The Promoters’ Holding
The promoters hold 86.65% of the pre-IPO capital
The Objects of the IPO
The Company proposes to utilize the Net Proceeds from Issue towards funding the following objects
| Objects of the Issue | Rs in Millions |
| Capital Expenditure Requirement | 91.2 |
| Working Capital Requirement | 158.8 |
| General Corporate Purposes |
Financials Snapshot
| Period Ended | 31-May-24 | 31-Mar-24 | 31-Mar-23 | 31-Mar-22 |
| Assets | 105.98 | 105.95 | 93.89 | 93.08 |
| Total Income | 3.99 | 92.55 | 80.19 | 71.07 |
| Profit After Tax | 0.48 | 10.51 | 5.08 | 4.51 |
| Net Worth | 73.21 | 72.73 | 63.54 | 59.75 |
| Reserves and Surplus | 69.07 | 68.58 | 59.4 | 55.61 |
| Total Borrowing | 25.22 | 23.54 | 19.17 | 23.58 |
| Amount in Rs. Crore | ||||
Peer Comparison:
| Company name | P/E (x) | RoNW (%) |
| Sheel Biotech Ltd. | 14.45 | |
| Jain Irrigation Systems Limited | 143.97 | |
| Vrundavan Plantation Ltd | 14.24 |
Key Financial Indicators
| KPI | Values |
| ROE | 13.59% |
| ROCE | 16.34% |
| Debt/Equity | 0.32 |
| RoNW | 13.59% |
| EBITDA Margin | 14.71% |
| Price to Book Value | 1.26 |
| EPS | 7.03 |
| PER | 8.96 |
IPO Recommendation/Concise Review-
May Avoid
Quicklinks
- Market Analysis by Nagaraj Shetti
- Stock Market today by Vaishali Parekh
- Analysis by Kotak Securities
- Market Analysis by HDFC Securities
- Technical Analysis by Kotak Securities
- Technical Analysis by Samco Securities
- Reliance, Target & Stoploss
- Gold Analysis
- FII buy-Sell
- Technical Analysis
- Calls for the Day
- Currency Analysis
# This is only coverage of News related to Grey Market Premium & subject to rates. We do not deal in grey market premium. We do not recommend dealing in Grey Market. Investment decision based on Grey Market trends can be faulty.
